A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...
Humedics GmbH has announced the results of a retrospective study investigating the impact of the LiMAx test on clinical patient outcome after hepatectomy. Study results showed that the use of the ...
Humedics GmbH has announced the start of a clinical phase III trial. The main goal of this study is the early identification of low-risk patients after partial liver resection by the LiMAx test and ...
LiMAx (Humedics GmbH) is a point-of-care diagnostic test for the quantitative measurement of the ratio of breath levels of 13 CO 2 to 12 CO 2. This can be used as a measure of functional liver ...